product summary
Loading...
company name :
Novus Biologicals
other brands :
IMGENEX
product type :
antibody
product name :
SynGAP Antibody
catalog :
NBP2-27541
quantity :
0.1 mg
price :
409 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
reactivity :
human, mouse, zebrafish
application :
western blot
more info or order :
citations: 2
Reference |
---|
product information
master code :
NBP2-27541
SKU :
NBP2-27541
product name :
SynGAP Antibody
unit size :
0.1 mg
description :
The SynGAP Antibody from Novus is a goat polyclonal antibody to SynGAP. This antibody reacts with mouse,fish - danio rerio (zebrafish). The SynGAP Antibody has been validated for the following applications: Western Blot,Peptide ELISA.
target :
SynGAP
category :
Primary Antibodies
buffer :
Tris saline (20 mM Tris pH 7.3, 150 mM NaCl), 0.5% BSA
clonality :
Polyclonal
concentration :
0.5 mg/ml
conjugate :
Unconjugated
host :
Goat
immunogen :
Peptide with sequence C-ESAHIEREEYKLKEY corresponding to internal region (near C-Terminus) according to NP_006763.2.
isotype :
IgG
purity :
Immunogen affinity purified
species :
Mouse,Fish - Danio rerio (Zebrafish)
gene symbol :
SYNGAP1
accessionNumbers :
NP_006763.2
applications :
Western Blot,Peptide ELISA
USD :
409 USD
alt names :
DKFZp761G1421, KIAA1938135kDa, MRD5, synaptic Ras GTPase activating protein 1, synaptic Ras GTPase activating protein 1 homolog (rat), Synaptic Ras-GAP 1
storage :
Store at -20C. Avoid freeze-thaw cycles.
more info or order :
company information

Novus Biologicals
10771 E Easter Ave
Centennial, CO 80112
Centennial, CO 80112
novus@novusbio.com
https://www.novusbio.com3037301950
headquarters: USA
Novus Biologicals licenses, manufactures, and markets antibodies to over 20,000 unique targets to support a wide array of research areas. Novus is built on honesty, collaboration and strong relationships and continues to provide quality tools that accelerate research. Every product is backed by our 100% guarantee.
related products
browse more products
questions and comments